280 related articles for article (PubMed ID: 17654685)
1. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts.
Nearman ZP; Szpurka H; Serio B; Warshawksy I; Theil K; Lichtin A; Sekeres MA; Maciejewski JP
Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685
[TBL] [Abstract][Full Text] [Related]
2. [Study on HFE gene mutations in patients with myelodysplastic syndromes and aplastic anemia].
Nie L; Ai XF; Zheng YZ; Li QH; Yang L; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):223-8. PubMed ID: 19731820
[TBL] [Abstract][Full Text] [Related]
3. High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients.
Várkonyi J; Tarkovács G; Karádi I; Andrikovics H; Varga F; Varga F; Demeter J; Tordai A
Acta Haematol; 2003; 109(2):64-7. PubMed ID: 12624489
[TBL] [Abstract][Full Text] [Related]
4. Haemochromatosis gene mutations in a clustered Italian population: evidence of high prevalence in people of Celtic ancestry.
Pozzato G; Zorat F; Nascimben F; Gregorutti M; Comar C; Baracetti S; Vatta S; Bevilacqua E; Belgrano A; Crovella S; Amoroso A
Eur J Hum Genet; 2001 Jun; 9(6):445-51. PubMed ID: 11436126
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
[TBL] [Abstract][Full Text] [Related]
6. JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Schmitt-Graeff AH; Teo SS; Olschewski M; Schaub F; Haxelmans S; Kirn A; Reinecke P; Germing U; Skoda RC
Haematologica; 2008 Jan; 93(1):34-40. PubMed ID: 18166783
[TBL] [Abstract][Full Text] [Related]
7. Nucleolar abnormalities--a defect of the nucleolar preribosome assembly--in ringed sideroblasts in refractory anaemia with ringed sideroblasts (RARS) of myelodysplastic syndrome (MDS). An electron microscopic study.
Smetana K; Cermák J; Jirásková I; Malasková V
Sb Lek; 2003; 104(2):199-207. PubMed ID: 14577129
[TBL] [Abstract][Full Text] [Related]
8. HFE genotype and iron metabolism in Chinese patients with myelodysplastic syndromes and aplastic anemia.
Nie L; Li L; Yang L; Zhang Y; Xiao Z
Ann Hematol; 2010 Dec; 89(12):1249-53. PubMed ID: 20563578
[TBL] [Abstract][Full Text] [Related]
9. Population-based study of the relationship between mutations in the hemochromatosis (HFE) gene and arthritis.
Sherrington CA; Knuiman MW; Divitini ML; Bartholomew HC; Cullen DJ; Olynyk JK
J Gastroenterol Hepatol; 2006 Mar; 21(3):595-8. PubMed ID: 16638105
[TBL] [Abstract][Full Text] [Related]
10. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
[TBL] [Abstract][Full Text] [Related]
11. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.
Passam FH; Tsirakis G; Boula A; Fragou A; Consolas I; Alegakis A; Kyriakou DS; Alexandrakis MG
Clin Lab Haematol; 2004 Dec; 26(6):391-5. PubMed ID: 15595996
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes.
Shikama Y; Shichishima T; Ohto H; Jubinsky PT; Maruyama Y
Br J Haematol; 2000 Dec; 111(3):863-72. PubMed ID: 11122148
[TBL] [Abstract][Full Text] [Related]
13. Hemochromatosis-causing mutations C282Y and H63D are not risk factors for atherothrombotic cerebral infarction.
Hruskovicová H; Milanez T; Kobal J; Potisk KP; Petrovic D; Peterlin B
Med Sci Monit; 2005 Jul; 11(7):BR248-52. PubMed ID: 15990686
[TBL] [Abstract][Full Text] [Related]
14. H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?
de Diego C; Opazo S; Murga MJ; Martínez-Castro P
Eur J Haematol; 2007 Jan; 78(1):66-71. PubMed ID: 17042772
[TBL] [Abstract][Full Text] [Related]
15. Detection of CD55- and CD59-deficient granulocytic populations in patients with myelodysplastic syndrome.
Kaiafa G; Papadopoulos A; Ntaios G; Saouli Z; Savopoulos C; Tsesmeli N; Kontoninas Z; Chatzinikolaou A; Tsavdaridou V; Klonizakis I; Hatzitolios A
Ann Hematol; 2008 Apr; 87(4):257-62. PubMed ID: 18158579
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome.
Cuijpers ML; Raymakers RA; Mackenzie MA; de Witte TJ; Swinkels DW
Br J Haematol; 2010 May; 149(3):322-33. PubMed ID: 20067561
[TBL] [Abstract][Full Text] [Related]
17. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Remacha AF; Nomdedéu JF; Puget G; Estivill C; Sarda MP; Canals C; Aventin A
Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
[TBL] [Abstract][Full Text] [Related]
19. HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.
De Souza GF; Ribeiro HL; De Sousa JC; Heredia FF; De Freitas RM; Martins MR; Gonçalves RP; Pinheiro RF; Magalhães SM
BMJ Open; 2015 Apr; 5(4):e006048. PubMed ID: 25841232
[TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.
Robinson G; Narasimhan S; Weatherall M; Beasley R
J Gastroenterol Hepatol; 2007 Jun; 22(6):852-4. PubMed ID: 17565641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
